Seller record · Telehealth service
Revel RX
Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the home page, the answers, the safety information page or the terms.
At a glance
Revel RXTelehealth service
- Price
- Semaglutide $89 a month, tirzepatide $155, same price every dose
- Sells
- compounded semaglutide, compounded tirzepatide
- FDA letters
- None on file
Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.
A telehealth weight loss service selling compounded semaglutide and tirzepatide at one monthly price for every dose, with no membership fee and prescribing by an outside clinician network. Care starts with an online health assessment, and its answers name two filling pharmacies with street addresses.
Operating entity Revel Rx LLC
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Revel RX's website; Revel RX's telehealth consent |
| S2 | Prescription gating | PASS | Revel RX's website |
| S3 | Pharmacy identification | PASS | Revel RX's website; Revel RX's return and refund policy |
| S4 | Compounding disclosure | PASS | Revel RX's website; Revel RX's about page |
| S5 | Analytical documentation | FAIL | Revel RX's website; Revel RX's important safety information page; Revel RX's terms of use page |
| S6 | Business address | PASS | Revel RX's contact page; Revel RX's terms of use page; Revel RX's privacy policy |
| S7 | Price disclosure | PASS | Revel RX's website |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.
Other sellers of the same products
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.